A partir de tradutores profissionais, empresas, páginas da web e repositórios de traduções disponíveis gratuitamente
fabry disease
Νόσος fabry
Última atualização: 2017-04-26
Frequência de uso: 1
Qualidade:
diagnosis of fabry disease
long- term replacement therapy in patients with a confirmed diagnosis of fabry disease
Última atualização: 2011-10-23
Frequência de uso: 1
Qualidade:
Aviso: esta concordância pode estar incorreta.
Exclua-a, se este for o caso.
replagal is used to treat fabry disease.
Το replagal χρησιμοποιείται για την αντιμετώπιση της Νόσου του fabry.
Última atualização: 2011-10-23
Frequência de uso: 2
Qualidade:
Aviso: esta concordância pode estar incorreta.
Exclua-a, se este for o caso.
fabry disease fabry disease chronic myeloid leukaemia
Νόσος του fabry Νόσος του fabry Χρόνεια µυελογενής λευχαιµία
Última atualização: 2011-10-23
Frequência de uso: 1
Qualidade:
Aviso: esta concordância pode estar incorreta.
Exclua-a, se este for o caso.
these reported symptoms resemble the natural course of fabry disease.
Αυτά τα αναφερόμενα συμπτώματα προσομοιάζουν με τη φυσική πορεία της νόσου του fabry.
Última atualização: 2017-04-26
Frequência de uso: 1
Qualidade:
fabrazyme is used to treat patients who have fabry disease, a rare inherited disorder.
Το fabrazyme χρησιμοποιείται για τη θεραπεία ασθενών που πάσχουν από τη νόσο fabry, μία σπάνια κληρονομική διαταραχή.
Última atualização: 2012-04-11
Frequência de uso: 3
Qualidade:
your treatment will be supervised by a doctor who specialises in the treatment of fabry disease.
Την αγωγή σας θα επιβλέπει ιατρός ειδικευμένος στη θεραπεία της Νόσου του fabry.
Última atualização: 2017-04-26
Frequência de uso: 4
Qualidade:
patients with fabry disease do not have enough of an enzyme, alpha-galactosidase a.
Οι ασθενείς που πάσχουν από τη νόσο του fabry παρουσιάζουν ανεπάρκεια ενός ενζύµου, της α- γαλακτοσιδάσης Α.
Última atualização: 2012-04-11
Frequência de uso: 2
Qualidade:
patients with fabry disease do not have enough of an enzyme called alpha-galactosidase a.
Οι ασθενείς με τη νόσο του fabry έχουν ανεπάρκεια ενός ενζύμου που ονομάζεται α- γαλακτοσιδάση Α.
Última atualização: 2012-04-11
Frequência de uso: 3
Qualidade:
fabry disease is an inherited heterogeneous and multisystemic progressive disease, that affects both males and females.
Η νόσος fabry είναι μια κληρονομική ετερογενής και πολυσυστηματική κλιμακούμενη νόσος, η οποία προσβάλλει τόσο τους άνδρες όσο και τις γυναίκες.
Última atualização: 2017-04-26
Frequência de uso: 5
Qualidade:
the effectiveness of fabrazyme was also tested in 16 children aged between eight and 16 years who had fabry disease.
Η αποτελεσματικότητα του fabrazyme εξετάστηκε επίσης σε 16 παιδιά με νόσο του fabry ηλικίας μεταξύ οχτώ και 16 ετών.
Última atualização: 2012-04-11
Frequência de uso: 3
Qualidade:
the chmp decided that for patients with fabry disease treatment with replagal might provide long- term clinical benefits.
Η chmp έκρινε ότι η θεραπεία με replagal μπορεί να έχει μακροπρόθεσμα κλινικά οφέλη για τους ασθενείς που πάσχουν από τη νόσο του fabry.
Última atualização: 2017-04-26
Frequência de uso: 1
Qualidade:
fabrazyme is indicated for use as long-term enzyme replacement therapy in patients with a confirmed diagnosis of fabry disease.
Το fabrazyme ενδείκνυται για χρήση σε μακροχρόνια θεραπεία ενζυμικής υποκατάστασης σε ασθενείς με επιβεβαιωμένη διάγνωση της νόσου fabry.
Última atualização: 2017-04-26
Frequência de uso: 5
Qualidade:
the chmp decided that, for patients with fabry disease, treatment with fabrazyme might provide long- term clinical benefits.
Η chmp έκρινε ότι η θεραπεία με fabrazyme μπορεί να έχει μακροπρόθεσμα κλινικά οφέλη για τους ασθενείς που πάσχουν από τη νόσο του fabry.
Última atualização: 2017-04-26
Frequência de uso: 1
Qualidade:
fabrazyme treatment should be supervised by a physician experienced in the management of patients with fabry disease or other inherited metabolic diseases.
Το φαρμακευτικό προϊόν αυτό θα πρέπει να χρησιμοποιείται υπό την επίβλεψη ιατρού με εμπειρία στην αντιμετώπιση ασθενών που πάσχουν από τη nόσο του fabry ή άλλες κληρονομικές μεταβολικές νόσους.
Última atualização: 2012-04-11
Frequência de uso: 4
Qualidade:
fabrazyme is indicated for long-term enzyme replacement therapy in patients with a confirmed diagnosis of fabry disease (-galactosidase a deficiency) .
Το fabrazyme ενδείκνυται για μακροχρόνια θεραπεία ενζυμικής υποκατάστασης σε ασθενείς με επιβεβαιωμένη διάγνωση της νόσου fabry (ανεπάρκεια της α-γαλακτοσιδάσης Α) .
Última atualização: 2008-03-04
Frequência de uso: 2
Qualidade:
Aviso: esta concordância pode estar incorreta.
Exclua-a, se este for o caso.
replagal is indicated for long-term enzyme replacement therapy in patients with a confirmed diagnosis of fabry disease (α-galactosidase a deficiency).
Το replagal ενδείκνυται ως μακροχρόνια θεραπεία ενζυμικής αντικατάστασης σε ασθενείς με επιβεβαιωμένη διάγνωση της nόσου του fabry (ανεπάρκεια α-γαλακτοζιδάσης Α).
Última atualização: 2017-04-26
Frequência de uso: 3
Qualidade:
in the open-label paediatric study, sixteen patients with fabry disease (8-16 years old; 14 males, 2 females) had been treated for one year.
Στην παιδιατρική μελέτη ανοικτού τύπου, δεκαέξι ασθενείς με νόσο του fabry (8-16 ετών, 14 άνδρες, 2 γυναίκες) υποβλήθηκαν σε θεραπεία επί ένα έτος.
Última atualização: 2017-04-26
Frequência de uso: 6
Qualidade: